Skip to content
Back to Guavy Wire
Stocks

Merck Dispute with Indian Pharma Co. Belongs in India, Says Third Circuit

Instruments
MRK
Share

The Third Circuit has ruled that a dispute between Merck and a defunct Indian pharmaceutical company belongs in India. The case revolves around a terminated business relationship.

Merck is involved in a long-standing dispute with the Indian company, but the court has decided that it should be litigated in India rather than in the US.

The Third Circuit's decision means that any further proceedings will take place in India. This ruling sets a precedent for similar cases in the future.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc